The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Koya, Richard
Item TypeName
Concept Melanoma, Experimental
Concept Melanoma
Concept gp100 Melanoma Antigen
Academic Article A novel AKT1 mutant amplifies an adaptive melanoma response to BRAF inhibition.
Academic Article Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy.
Academic Article MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
Academic Article CTLA4 blockade broadens the peripheral T-cell receptor repertoire.
Academic Article Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
Academic Article The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
Academic Article CTLA4 blockade increases Th17 cells in patients with metastatic melanoma.
Academic Article Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation.
Academic Article Melanoma whole-exome sequencing identifies (V600E)B-RAF amplification-mediated acquired B-RAF inhibitor resistance.
Academic Article Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.
Academic Article Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma.
Academic Article BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
Academic Article Natural killer T cells in advanced melanoma patients treated with tremelimumab.
Academic Article CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans.
Academic Article Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines.
Academic Article Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.
Academic Article Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance.
Academic Article Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.
Academic Article Measurement and Quantitative Characterization of Whole-Body Pharmacokinetics of Exogenously Administered T Cells in Mice.
Academic Article Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.
Academic Article CD4+CD25- T cells transduced to express MHC class I-restricted epitope-specific TCR synthesize Th1 cytokines and exhibit MHC class I-restricted cytolytic effector function in a human melanoma model.
Academic Article The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
Academic Article Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect.
Academic Article siRNA knockdown of ribonucleotide reductase inhibits melanoma cell line proliferation alone or synergistically with temozolomide.
Academic Article Preexisting MEK1 exon 3 mutations in V600E/KBRAF melanomas do not confer resistance to BRAF inhibitors.
Academic Article Molecular mechanism of MART-1+/A*0201+ human melanoma resistance to specific CTL-killing despite functional tumor-CTL interaction.
Academic Article Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Academic Article Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.
Academic Article Immunosensitization with a Bcl-2 small molecule inhibitor.
Academic Article Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction.
Academic Article Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition.
Academic Article Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Academic Article Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.
Search Criteria
  • Melanoma